Literature DB >> 27578456

STAT4 is required for the generation of Th1 and Th2, but not Th17 immune responses during monophosphoryl lipid A adjuvant activity.

Sanjay Varikuti1, Steve Oghumu2, Gayathri Natarajan3, Jennifer Kimble1, Rachel H Sperling1, Ellen Moretti1, Mark H Kaplan4, Abhay R Satoskar5,3.   

Abstract

STAT4 is critical for the production of IFN-γ during the generation of Th1 immune responses. We investigated the role of STAT4 in mediating Th1-inducing activity of a vaccine adjuvant monophosphoryl lipid A (MPL-A) using the standard antigen ovalbumin (OVA) in STAT4KO mice. Our results show that splenocytes from STAT4KO mice displayed lower OVA-specific T-cell proliferation and IL-2 production compared with wild-type (WT) mice. Further, IFN-γ production was diminished in STAT4KO-derived splenocytes but the levels of IL-12 and TNF-α were similar compared with WT mice. Interestingly, STAT4 deficiency also led to a decrease in IL-10 and Th2 cytokines such as IL-4 and IL-13 upon MPL-A immunization, although IL-17 production was similar between WT- and STAT4KO-derived splenocytes. Our observations for defective Th1 and Th2 responses in STAT4KO mice were further supported by the low levels of Th1-associated IgG2a and Th2-associated IgG1 in the sera of these mice. Taken together, our results show that STAT4 plays a critical role in mediating both Th1 and Th2 responses upon immunization with MPL-A. Our study provides a better understanding of how MPL-A mediates T-cell activation which will be critical for future vaccine development. © The Japanese Society for Immunology. 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IFN-γ; IL-2; IL-4; T cells; vaccine

Mesh:

Substances:

Year:  2016        PMID: 27578456      PMCID: PMC6018885          DOI: 10.1093/intimm/dxw038

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  32 in total

1.  The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1.

Authors:  A Moore; L McCarthy; K H Mills
Journal:  Vaccine       Date:  1999-06-04       Impact factor: 3.641

2.  The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells.

Authors:  G De Becker; V Moulin; B Pajak; C Bruck; M Francotte; C Thiriart; J Urbain; M Moser
Journal:  Int Immunol       Date:  2000-06       Impact factor: 4.823

Review 3.  Recent developments in adjuvants for vaccines against infectious diseases.

Authors:  D T O'Hagan; M L MacKichan; M Singh
Journal:  Biomol Eng       Date:  2001-10-15

Review 4.  The role of interleukin-2 during homeostasis and activation of the immune system.

Authors:  Onur Boyman; Jonathan Sprent
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

5.  Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF.

Authors:  Hua Xin Liao; George J Cianciolo; Herman F Staats; Richard M Scearce; Dana M Lapple; Stephen H Stauffer; James R Thomasch; Salvatore V Pizzo; David C Montefiori; Michael Hagen; John Eldridge; Barton F Haynes
Journal:  Vaccine       Date:  2002-05-22       Impact factor: 3.641

6.  Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice.

Authors:  P Hochholzer; G B Lipford; H Wagner; K Pfeffer; K Heeg
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 7.  The march toward malaria vaccines.

Authors:  Stephen L Hoffman; Johan Vekemans; Thomas L Richie; Patrick E Duffy
Journal:  Vaccine       Date:  2015-08-29       Impact factor: 3.641

8.  Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation.

Authors:  K Yamamoto; F W Quelle; W E Thierfelder; B L Kreider; D J Gilbert; N A Jenkins; N G Copeland; O Silvennoinen; J N Ihle
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

9.  Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens.

Authors:  D J Rawlings; D C Kaslow
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

10.  A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8(+) T Cells.

Authors:  Mithun Maji; Saumyabrata Mazumder; Souparno Bhattacharya; Somsubhra Thakur Choudhury; Abdus Sabur; Md Shadab; Pradyot Bhattacharya; Nahid Ali
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

View more
  5 in total

1.  Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice.

Authors:  Saeed Nazeri; Sedigheh Zakeri; Akram A Mehrizi; Navid D Djadid; Georges Snounou; Chiara Andolina; François Nosten
Journal:  Med Microbiol Immunol       Date:  2018-06-09       Impact factor: 3.402

2.  Silencing of STAT4 Protects Against Autoimmune Myocarditis by Regulating Th1/Th2 Immune Response via Inactivation of the NF-κB Pathway in Rats.

Authors:  Yu-Long Xue; Sheng-Xiao Zhang; Chao-Feng Zheng; Yu-Feng Li; Li-Hui Zhang; Yu-Fei Hao; Shu Wang; Xue-Wen Li
Journal:  Inflammation       Date:  2019-08       Impact factor: 4.092

3.  'Psoriasis 1' reduces T‑lymphocyte‑mediated inflammation in patients with psoriasis by inhibiting vitamin D receptor‑mediated STAT4 inactivation.

Authors:  Yang Gao; Wen Sun; Xushan Cha; Hailong Wang
Journal:  Int J Mol Med       Date:  2020-08-06       Impact factor: 4.101

4.  Immune Suppression Mediated by STAT4 Deficiency Promotes Lymphatic Metastasis in HNSCC.

Authors:  Kelvin Anderson; Nathan Ryan; Greta Volpedo; Sanjay Varikuti; Abhay R Satoskar; Steve Oghumu
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561

5.  Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.

Authors:  Jessamine E Hazlewood; Troy Dumenil; Thuy T Le; Andrii Slonchak; Stephen H Kazakoff; Ann-Marie Patch; Lesley-Ann Gray; Paul M Howley; Liang Liu; John D Hayball; Kexin Yan; Daniel J Rawle; Natalie A Prow; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2021-01-13       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.